Transferable metallo-␤-lactamases (M␤Ls) are important resistance determinants in Acinetobacter spp. and Pseudomonas aeruginosa in hospitals (15, 16) . M␤Ls , not yet frequent, are also disseminating among the members of the family Enterobacteriaceae (4, 11) . Transferable M␤Ls belong to two major groups, IMP and VIM alleles. Recently, a novel variant of the VIM family, VIM-5, was detected in Klebsiella pneumoniae and P. aeruginosa clinical strains in Turkey (1, 10) . We detected a VIM-5-producing Enterobacter cloacae isolate in a collection of clinical strains isolated before 2002 in a university hospital located in the southeast part of Turkey.
E. cloacae EDV/1 was identified in a collection of clinical isolates obtained from the Hospital of Dicle University (Turkey). It was isolated before 2002. The Escherichia coli strain ER2267 obtained from New England Biolabs was used as a host for cloning procedures, and the rifampin-resistant E. coli strain J-53-2 was used for transconjugation experiments (18) . Plasmids pACYCDuet-1 (Novagen, Darmstadt, Germany) and pUC19 were the vectors used for cloning and subcloning experiments.
The MICs of antibiotics were determined by the broth microdilution method according to the guidelines of the Clinical and Laboratory Standards Institute (formerly NC-CLS). Plasmid isolation and transconjugation experiments were described elsewhere (18) . Hybridization and detection steps were accomplished with the digoxigenin (DIG)-dUTP detection kit as recommended by the manufacturer (Boehringer Mannheim, GmbH) (19 E. cloacae EDV/1 was identified with reduced susceptibility to ␤-lactam antibiotics in a set of clinical isolates stored before 2002 in a university hospital located in southeast Turkey. The crude enzyme extract of EDV/1 showed carbapenemase activity typical of metalloenzymes. A PCR screen with consensus primers of IMP and VIM family metallo-␤-lactamases was performed (data not shown). Upon detection of a VIM allele with PCR, a DIG-dUTP-labeled probe was generated. Hybridization experiments with this probe detected bla VIM on an approximately 3,900-bp (BamHI) or 2,712-bp (BamHI-HindIII) fragment of an approximately 23-kbp plasmid, pEDV5 ( Fig. 1) , which seems to be nonconjugative. Sequence analysis of the bla gene was identical to that of VIM-5 (GenBank accession no. AY910754).
The BamHI fragment of the plasmid (pEDV5) shown to carry bla VIM-5 was successfully inserted into the vector pACYCDuet-1 (pACDV5/4). A BamHI-HindIII double digestion of this plasmid yielded two fragments from the insert. These fragments were inserted into pUC19 as pUCSCV5/1 (2,712 bp) and pUCSCV5/2 (approximately 1,100 bp). The VIM-5 gene was located on the plasmid pUCSCV5/1. Sequence analysis of this insert showed that bla VIM-5 is associated with a class 1 integron as a single antibiotic resistance gene cassette, followed by orfD and qacEdelta1 genes ( Fig. 2 ) (GenBank accession no. DQ023222).
VIM-1 was first reported from Italy in 1999 (6) and is now prevalent in the northern part of the same country (2, 8) . However, a recent retrospective study determined that VIM-1 was present in a P. aeruginosa isolate from a collection of strains stored in 1996 in a Greek hospital (17) . Likewise, VIM-4 was first detected in Greece (14) and was then found in Poland (12), Hungary (7), and Italy (9) . In Hungary the VIM-4 outbreak was related to a Greek patient visiting the country. Current knowledge, therefore, raises the probability that VIM-1 and later VIM-4 evolved in Greek hospitals and was disseminated by carriers (17) . The present study shows that VIM-5 existed before 2002 and is now scattered around hospitals in different parts of Turkey. These evolutionarily related VIMs occurred in countries geographically close to one another. However, whether this figure represents a unifocal epidemic of VIM-1, VIM-4, and VIM-5 has not been documented so far. Moreover, we do not have data for the dissemination of VIM alleles in countries bordering the eastern part of Turkey.
Although the crude enzyme extract failed, purified VIM-5 was visible at a pI of approximately 4.5 on the IEF gel. According to sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis, the molecular mass of VIM-5 was calculated as 28 kDa and the purity of the protein was Ͼ90%. The purification steps are summarized in Table 1 . Kinetic parameters k cat , K m , and k cat /K m were determined with clinically significant ␤-lactam antibiotics. All ␤-lactams with significant differences in k cat and K m values were hydrolyzed by VIM-5, with the exception of aztreonam (Table 2) . Notably, ceftazidime and cefepime were less effectively hydrolyzed by VIM-5 than VIM-1 (3) and VIM-2 (13), while cefotaxime was hydrolyzed at a comparable efficacy to that of VIM-2. The behavior of VIM-5 against carbapenems was similar to that of VIM-1 and VIM-2, with greater efficiency on imipenem than meropenem. VIM-5 was inhibited by EDTA (50% inhibitory concentration, 20 M EDTA).
MICs for the wild-type strain E. cloacae EDV/1 and the clones are presented in Table 3 . The MICs of cefepime and carbapenems for both the wild-type strain and clones were in the susceptible breakpoint range. Although these antibiotics are hydrolyzed by VIM-5, the genotypic resistance is masked in susceptibility tests when the recommended inoculum size is applied. However, significant differences were observed between the MICs in independent experiments. Slight changes in inoculum (not more than 10-fold) caused significant changes in MICs (2 g/ml versus 16 g/ml for imipenem; 4 g/ml versus 32 g/ml for meropenem). Such striking discrepancies were observed with VIM-1 and VIM-4 as well (5, 9) .
Finally, the present data show that VIM-5 entered Turkish hospitals before 2002, and it is now found in distinct centers.
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